Podcast: Who are the Uninsured in America?
In this podcast episode, Patricia Ensor discusses the characteristics and behaviors of the uninsured, how they relate to the Affordable Care Act (ACA), and what it means for Pharma.
Play podcast
White Paper: The Uninsured in America - What do characteristics and behaviors tell us about likely participation in the healthcare exchange marketplace?
Based on simulations and projections conducted by multiple groups to date, it is still uncertain who and how many uninsured will, in fact, obtain insurance. Kantar Health undertook an analysis to increase the body of knowledge about the currently uninsured patients. The results are contained in this white paper.
Download white paper
PharmaVOICE Editors' Blog
Showing posts with label ACA. Show all posts
Showing posts with label ACA. Show all posts
Monday, February 24, 2014
The Uninsured in America - podcast and white paper
Posted by
Anonymous
at
11:15 AM
Labels:
ACA,
Kantar Health,
Obamacare,
pharmavoice,
podcast,
uninsured,
white paper,
whitepaper
Friday, September 20, 2013
Are You Prepped for a Health Care Hurricane?
Posted by
Anonymous
at
9:29 AM
![]() |
| Are we prepared for a possible health care storm? |
It's hurricane season, and it's also the season of the Patient Protection and the Affordable Care Act. Obviously this directly affects the Pharmaceutical industry. Will it be a Class 5 disaster or a pleasant tropical breeze? We clearly don't know. Predictions abound, and many political factions are posturing and offering their thoughts. Most offer an extreme outlook on one side or the other.
I've visited over a dozen web sites this week looking for some consistency. I scoured news sites, analyst sites, and manufacturer sites, and I still have no clear idea how this will play out. The range of opinions and lack of consensus is downright intimidating. Some say this will revolutionize health care for all Americans. Others say it will be a bumpy ride for years, before we get it right. And still others say it will be the demise of quality health care as we know it.
So here we sit with far more questions than answers. Here are just a few causing loss of sleep in our industry.
- Will some pharmaceutical companies take a financial hit under the new system, while others benefit?
- How will it affect our market share?
- Is our pipeline strategically sound given this new health care reform?
- How will company health care plans be overhauled under the new plan?
- Will patients receive better treatment?
- Will HCPs know how to navigate the system?
- Will payers be able to process the reimbursements properly and in a timely manner?
I must admit that I don't trust any of the predictions I read. The issues are polarized beyond understanding. This is one instance where we should prepare for the worst and hope for the best. The key here is preparation.
Here are some points every pharmaceutical company should review before the program begins enrolling patients on October 1.
- Are we prepared to make quick and informative communications to the public?
- Have we game planned many of the possible issues that may arise?
- Will we add clarity or chaos to the mix of information?
- Is our customer service group staffed up and adequately trained?
- Have our reps been communicating with their HCP clients about the changes under the PPACA?
- Have we been working with providers and plans to ensure we are in compliance with their new processes?
- Are our pharmacy customers comfortable with the new processes for receiving and dispensing our products?
What are your thoughts on the PPACA? Leave a comment.
Labels:
ACA,
health care,
health care reform,
Obamacare,
pharmaceutical,
ppaca
Thursday, December 20, 2012
Hospital of the (Near) Future
Posted by
Anonymous
at
11:01 AM
![]() |
| Every aspect of the building will be designed for the patient |
The typical hospital room, with its beige walls and stingy windows, carries a dim, funereal cast and works against patient well-being. The standard twin-bedded configuration doesn't help, fostering the spread of infection, making sleep difficult, and giving people at their sickest the dignity of life in a freshman dorm.The latest issue of Fast Company magazine covers an emerging movement for modern, well-designed hospitals that cater to the patient, not just the doctors and nurses who pop in for a few minutes at a time. Administrators used to think cramming more patients in the same space was good for the bottom line. Maybe it was back then. Nobody likes to share a room with other patients when they are sick and uncomfortable, and patients have more choices for healthcare than they did in the past.
The new look hospitals will be a godsend to patients. All patients will have their own room, with large windows and comfortable beds. The rooms will be tech-savvy with a media wall, hi-speed WiFi and other modern technologies. Video chats can replace phone calls between patients and family or friends. Bathrooms will be spacious and accommodating - in contrast, many old hospital bathrooms aren't even large enough for a walker. In the new designs, nurses will have better line-of-sight angles to monitor their patients.
![]() |
| Single rooms for every patient - well appointed |
![]() |
| Slanted rooms give patients views of the outside and of the media wall |
These changes are already in the works in some places, but the overall hospital system won't change overnight. While some new hospitals are utilizing these new designs, it will take decades to revamp or rebuild a majority of the 5,800 hospitals in the U.S. The best of the new hospitals will be built from the ground up, rather than retooling existing buildings.
Better hospitals will improve the level of care we can provide. This is exactly the kind of innovation we need.
Labels:
ACA,
Fast Company,
health care,
healthcare,
hospitals,
limbach,
medicare,
Obamacare,
patients
Tuesday, August 21, 2012
Supreme Court Upheld the ACA. What Do You Do Now? Attend Webinar
Posted by
Anonymous
at
5:29 PM
![]() |
| The ACA has broad-reaching ramifications for health care |
I've been working very hard on our next webinar. The topic is about how the ACA will affect health care from a pharma/biotech company perspective. It features some exciting new research findings about how physicians, payers, and pharmaceutical companies will have to adjust to the new system. It also details some interesting and valuable patient perceptions you can't get anywhere else.
There is no cost to attend.
Building Winning Strategies in an ACA World: Your Guide to Success in a Value-Driven Market
Date and Time: September 20, 2012 11:00am EST, 4:00pm GMT (60 minutes)
Please take 3 minutes to register for this webinar.
http://bit.ly/WGwebinar
It's informative. It's interactive. You and your peers will participate in live polls and can even submit questions to the panelists for the Q & A session. I'll be your moderator.
The webinar is designed to explain:
- How the ACA may impact cost-containment pressures, payer accountability and market conditioning
- What US marketers can learn from EU experiences to help them adapt successfully to ACA
- How the development and communication of clinical and economic value messages are changing, with the shift toward evidence-based medicine and comparative effectiveness research
- Why determining value drivers as early as possible in the clinical and commercial development process is critical for any brand
If you cannot attend the live event, but want to access the OnDemand version, please register now, so that you receive the OnDemand access information via email after the event.
Learn more and register at
http://bit.ly/WGwebinar
I hope to see you online on September 20!
Labels:
ACA,
health care reform,
limbach,
Obamacare,
webinar
Subscribe to:
Posts (Atom)

.jpg)




